Taizhou Mabtech Pharmaceutical Co.,ltd

This study tests a new drug, omalizumab α, against the approved drug Xolair for people with chronic hives that don't get better with antihistamines. About 392 adults aged 15 to 75 will receive either drug for 12 weeks to see how well it reduces itching and hives. The goal is to f…

This early-stage study tests a new drug called CMAB015, which is similar to the approved psoriasis treatment Cosentyx. It involves 114 healthy Chinese men to see how the body processes the drug, its safety, and whether it triggers an immune response. The goal is to compare the ne…

This study checks if changing how EnliTuo® is made affects how the drug behaves in the body. About 86 healthy men will receive a single dose and be monitored for safety and drug levels. The goal is to compare the old and new versions, not to treat any disease.